Replies to post #233162 on Biotech Values

[DewDiligence]

REXN—>OCUP—1:4_reverse_split_effective_at_close_today—pursuant to previously announced reverse-merger:

https://www.globenewswire.com/news-release/2020/11/05/2121337/0/en/Rexahn-Pharmaceuticals-Announces-Expected-Effectiveness-of-Reverse-Stock-Split-and-Merger-Transaction-with-Ocuphire-Pharma.html

[DewDiligence]

OCUP +110%/PM on phase-3 success in reversal of drug-induced pupil dilation:

https://www.globenewswire.com/news-release/2021/03/15/2192556/0/en/Ocuphire-Announces-MIRA-2-Phase-3-Registration-Trial-for-the-Reversal-of-Mydriasis-Meets-Primary-Endpoint.html

OCUP is the result of a reverse-merger announced in Jun 2020 (#msg-156362145).